INTERLEUKIN RECEPTOR TARGETED MOLECULES FOR TREATMENT OF INFLAMMATORY ARTHRITIS - Patent 0668774

(19)

(11)

EP 0 668 774 A1

(12)

(43)	Date of publication:
	30.08.1995 Bulletin 1995/35

(21)	Application number: 92912075.0

(22)	Date of filing: 04.05.1992

(51)

International Patent Classification (IPC):

A61K 35/ 74^{( . )}
A61K 39/ 395^{( . )}
A61P 29/ 00^{( . )}
C07K 14/ 22^{( . )}
C07K 14/ 55^{( . )}

A61K 38/ 00^{( . )}
A61K 47/ 48^{( . )}
A61P 43/ 00^{( . )}
C07K 14/ 54^{( . )}

(86)	International application number:
	PCT/US1992/003714

(87)	International publication number:
	WO 1992/019259 (12.11.1992 Gazette 1992/28)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

(30)

Priority:

03.05.1991 US 19910695480
30.04.1992 US 19920876521

(71)	Applicant: SERAGEN, INC.
	Hopkinton, MA 01748 (US)

(72)	Inventors:
	WOODWORTH, Thasia, G. Watch Hill, RI 02819 (US) NICHOLS, Jean, C. Wayland, MA 01778 (US) BACHA, Patricia, A. Hollis, NH 03049 (US)

(74)	Representative: Wright, Simon Mark, et al
	Kilburn & Strode 30 John Street London WC1N 2DD London WC1N 2DD (GB)

(54)	INTERLEUKIN RECEPTOR TARGETED MOLECULES FOR TREATMENT OF INFLAMMATORY ARTHRITIS